A detailed history of M&G Investment Management LTD transactions in Biogen Inc. stock. As of the latest transaction made, M&G Investment Management LTD holds 8,593 shares of BIIB stock, worth $1.93 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,593
Previous 8,593 -0.0%
Holding current value
$1.93 Million
Previous $2.23 Billion -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 01, 2023

SELL
$275.25 - $318.06 $106,521 - $123,089
-387 Reduced 4.31%
8,593 $2.45 Billion
Q1 2023

May 11, 2023

SELL
$256.56 - $292.34 $991,091 - $1.13 Million
-3,863 Reduced 30.08%
8,980 $2.5 Million
Q3 2022

Nov 01, 2022

SELL
$194.69 - $268.46 $30,371 - $41,879
-156 Reduced 1.2%
12,843 $3.43 Million
Q4 2021

Jan 18, 2022

SELL
$223.92 - $287.77 $16.5 Million - $21.3 Million
-73,893 Reduced 85.04%
12,999 $3.12 Million
Q3 2021

Nov 09, 2021

BUY
$282.99 - $369.05 $7.86 Million - $10.3 Million
27,777 Added 46.99%
86,892 $24.6 Million
Q2 2021

Aug 16, 2021

BUY
$259.0 - $414.71 $10.7 Million - $17.2 Million
41,364 Added 233.02%
59,115 $20.5 Million
Q1 2021

May 12, 2021

SELL
$242.95 - $284.63 $1.14 Million - $1.34 Million
-4,711 Reduced 20.97%
17,751 $4.97 Million
Q4 2020

Feb 02, 2021

SELL
$236.26 - $355.63 $2.01 Million - $3.02 Million
-8,500 Reduced 27.45%
22,462 $5.5 Million
Q3 2020

Oct 26, 2020

SELL
$264.77 - $305.71 $381,268 - $440,222
-1,440 Reduced 4.44%
30,962 $8.79 Million
Q2 2020

Jul 22, 2020

BUY
$258.66 - $342.55 $3.43 Million - $4.54 Million
13,249 Added 69.17%
32,402 $8.68 Million
Q1 2020

Apr 09, 2020

SELL
$268.85 - $341.04 $9.49 Million - $12 Million
-35,290 Reduced 64.82%
19,153 $6.05 Million
Q4 2019

Jan 28, 2020

BUY
$220.06 - $304.07 $12 Million - $16.6 Million
54,443 New
54,443 $16.2 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $32.4B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track M&G Investment Management LTD Portfolio

Follow M&G Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&G Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on M&G Investment Management LTD with notifications on news.